Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she ...
Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR RNA-guided cleavage. Type V CRISPR-Cas (Cas12) systems, in particular, ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback